DK0585314T3 - - Google Patents

Info

Publication number
DK0585314T3
DK0585314T3 DK92910899.1T DK92910899T DK0585314T3 DK 0585314 T3 DK0585314 T3 DK 0585314T3 DK 92910899 T DK92910899 T DK 92910899T DK 0585314 T3 DK0585314 T3 DK 0585314T3
Authority
DK
Denmark
Prior art keywords
compounds
treating
useful
pharmaceutical compositions
nervous system
Prior art date
Application number
DK92910899.1T
Other languages
Danish (da)
English (en)
Inventor
Knud Erik Andersen
Lars Jacob Stray Knutsen
Per Olav Soerensen
Behrend Friedrich Lundt
Jesper Lau
Hans Petersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK0585314T3 publication Critical patent/DK0585314T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
DK92910899.1T 1991-05-17 1992-05-14 DK0585314T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK91937A DK93791D0 (da) 1991-05-17 1991-05-17 Nye heterocykliske carboxylsyrer
PCT/DK1992/000155 WO1992020658A1 (en) 1991-05-17 1992-05-14 Novel heterocyclic carboxylic acids

Publications (1)

Publication Number Publication Date
DK0585314T3 true DK0585314T3 (fi) 1997-05-05

Family

ID=8099201

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91937A DK93791D0 (da) 1991-05-17 1991-05-17 Nye heterocykliske carboxylsyrer
DK92910899.1T DK0585314T3 (fi) 1991-05-17 1992-05-14

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK91937A DK93791D0 (da) 1991-05-17 1991-05-17 Nye heterocykliske carboxylsyrer

Country Status (16)

Country Link
US (1) US5348965A (fi)
EP (1) EP0585314B1 (fi)
JP (1) JPH06507616A (fi)
AT (1) ATE143009T1 (fi)
AU (1) AU665761B2 (fi)
CA (1) CA2102811A1 (fi)
DE (1) DE69213935T2 (fi)
DK (2) DK93791D0 (fi)
ES (1) ES2094357T3 (fi)
FI (1) FI103116B1 (fi)
GR (1) GR3021822T3 (fi)
IL (1) IL101887A (fi)
NO (1) NO300211B1 (fi)
NZ (1) NZ242759A (fi)
WO (1) WO1992020658A1 (fi)
ZA (1) ZA923556B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK74393D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
DK74493D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
DK74693D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
IL112223A0 (en) * 1994-01-04 1995-03-30 Novo Nordisk As Pharmaceutical compositions for the treatment of neurological inflammatory conditions
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
US5698551A (en) * 1995-04-07 1997-12-16 Novo Nordisk A/S Heterocyclic compounds
WO1997022342A1 (en) * 1995-12-15 1997-06-26 Novo Nordisk A/S Novel method
WO1999000376A1 (en) * 1997-06-25 1999-01-07 Novo Nordisk A/S Novel heterocyclic compounds
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
US6468996B1 (en) * 1998-10-21 2002-10-22 Novo Nordisk A/S Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
CN1382441A (zh) * 2002-05-21 2002-12-04 中国科学院上海生命科学研究院 γ-氨基丁酸转运蛋白抑制剂在制备镇痛药物中的应用
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE562299A (fi) * 1956-11-15
BE560750A (fi) * 1957-07-26
CH368178A (de) * 1958-09-10 1963-03-31 Geigy Ag J R Verfahren zur Herstellung von neuen basisch substituierten heterocyclischen Verbindungen
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer

Also Published As

Publication number Publication date
FI103116B (fi) 1999-04-30
DE69213935T2 (de) 1997-03-27
NZ242759A (en) 1995-03-28
IL101887A0 (en) 1992-12-30
CA2102811A1 (en) 1992-11-26
AU665761B2 (en) 1996-01-18
EP0585314B1 (en) 1996-09-18
ZA923556B (en) 1993-01-27
FI103116B1 (fi) 1999-04-30
JPH06507616A (ja) 1994-09-01
FI935064A0 (fi) 1993-11-16
NO934159D0 (no) 1993-11-17
AU1783792A (en) 1992-12-30
ES2094357T3 (es) 1997-01-16
US5348965A (en) 1994-09-20
IL101887A (en) 1996-10-16
EP0585314A1 (en) 1994-03-09
FI935064A (fi) 1993-11-16
ATE143009T1 (de) 1996-10-15
WO1992020658A1 (en) 1992-11-26
NO300211B1 (no) 1997-04-28
GR3021822T3 (en) 1997-02-28
DK93791D0 (da) 1991-05-17
DE69213935D1 (en) 1996-10-24
NO934159L (no) 1993-11-17

Similar Documents

Publication Publication Date Title
GR3032207T3 (en) 2-Bromomelatonin in the therapy of sleep disorders
GB9410987D0 (en) High dosage pharmaceutical compositions
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
DK0585314T3 (fi)
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
NO981436L (no) Farmas÷ytiske angiostatiske dipeptidsammensetninger og anvendelse derav
HUT68969A (en) Bis-naphthalimides containing amino-acid derivatived linkers as anticancer agents
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
BG101040A (en) Benzopyrans and their use as therapeutic agents
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
GB9410898D0 (en) Pharmaceutical compositions having analgesic activity
ZA979647B (en) Heterocyclic compounds, compositions and uses.
IL109076A0 (en) Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
MY107976A (en) Improvements in or relating to organic compounds
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
ZA979650B (en) Heterocyclic compounds, compositions and uses.
ZA979645B (en) Heterocyclic compounds, compositions and uses.
BG102638A (en) Tablets having increased phamcyclovir content
GR3015132T3 (en) Novel ureas and thioureas, preparation thereof and application in therapy.
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
DK0608648T3 (da) Højdoserede vitamin A-præparater
MX9606304A (es) Benzopiranos y uso como agentes terapeuticos.
JO1711B1 (en) Therapeutic agents
KR950018801U (ko) 투포원 연사기용 니들투입기